Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Paragon Care Limited ( (AU:PGC) ) has issued an announcement.
Paragon Care Limited has announced the acquisition of Somnotec Group, a distributor of medical devices in Southeast Asia, to expand its footprint in the region. This strategic acquisition is expected to enhance Paragon Care’s service capabilities across the Asia Pacific, with the deal valued at SGD24 million. The acquisition is anticipated to be earnings accretive by FY26 and is subject to regulatory approvals and other conditions.
The most recent analyst rating on (AU:PGC) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Paragon Care Limited stock, see the AU:PGC Stock Forecast page.
More about Paragon Care Limited
Paragon Care Limited is an Australian-based company in the healthcare sector, providing medical equipment, devices, consumables, pharmaceuticals, complementary medicines, nutritional supplies, and manufacturing Blood Bank diagnostic reagents for healthcare markets in Australia, New Zealand, and Asia.
Average Trading Volume: 519,321
Technical Sentiment Signal: Sell
Current Market Cap: A$480M
See more data about PGC stock on TipRanks’ Stock Analysis page.